Top Markets
Coin of the day
Neovasc Inc. Neovasc Inc.

Neovasc Inc.

NVCN
株式のランク #17840
Neovasc Inc. is a medical technology firm specializing in the design,... Neovasc Inc. is a medical technology firm specializing in the design, production, and global distribution of cardiovascular devices, particularly across European markets and beyond. Its primary offerings include the Tiara system, developed for the transcatheter treatment of mitral valve disease, and the Neovasc Reducer, used to address chronic, debilitating chest pain known as refractory angina. Established in 2000, the company, which maintains its headquarters in Richmond, Canada, was formerly named Medical Ventures Corp. before adopting its current identity, Neovasc Inc., in July 2008.
株価
$29.82
最終同期: 2023-04-11
時価総額
$223.68M
変化(1日)
1.21%
変化(1年)
0.00%
CA
取引 Neovasc Inc. (NVCN)

カテゴリー

Neovasc Inc.(NVCN)の配当利回りの履歴
Neovasc Inc.(銘柄コード: NVCN)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Neovasc Inc.(NVCN)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)